Nektar Therapeutics (NKTR) EBIT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,386.07% |
| 10 | Nektar Therapeutics | 1.60 Bn | 1.04 Bn | 3.16 Mn | 12.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.31% |
| Dec 31, 2025 | 443.30% |
| Sep 30, 2025 | 7.78% |
| Jun 30, 2025 | 27.21% |
| Mar 31, 2025 | -25.71% |
| Dec 31, 2024 | 142.82% |
| Sep 30, 2024 | 23.45% |
| Jun 30, 2024 | 1.63% |
| Mar 31, 2024 | 73.70% |
| Dec 31, 2023 | 36.13% |
| Sep 30, 2023 | 17.38% |
| Jun 30, 2023 | 66.89% |
| Mar 31, 2023 | -15.57% |
| Dec 31, 2022 | 53.53% |
| Sep 30, 2022 | 52.20% |
| Jun 30, 2022 | -38.68% |
| Mar 31, 2022 | -6.55% |
| Dec 31, 2021 | -1.98% |
| Sep 30, 2021 | -10.23% |
| Jun 30, 2021 | -41.82% |
| Mar 31, 2021 | 18.14% |
| Dec 31, 2020 | -0.99% |
| Sep 30, 2020 | -4.36% |
| Jun 30, 2020 | 29.97% |
| Mar 31, 2020 | -10.73% |
| Dec 31, 2019 | -9.32% |
| Sep 30, 2019 | -0.11% |
| Jun 30, 2019 | -111.40% |
| Mar 31, 2019 | -39.14% |
| Dec 31, 2018 | -317.30% |
| Sep 30, 2018 | -241.95% |
| Jun 30, 2018 | 2,021.98% |
| Mar 31, 2018 | -59.34% |
| Dec 31, 2017 | 25.23% |
| Sep 30, 2017 | 311.19% |
| Jun 30, 2017 | -32.17% |
| Mar 31, 2017 | -473.99% |
| Dec 31, 2016 | -9.47% |
| Sep 30, 2016 | -7,952.27% |
| Jun 30, 2016 | 11.83% |
| Mar 31, 2016 | -122.03% |
| Dec 31, 2015 | 21.67% |
| Sep 30, 2015 | -99.48% |
| Jun 30, 2015 | -89.69% |
| Mar 31, 2015 | 218.24% |
| Dec 31, 2014 | -4.44% |
| Sep 30, 2014 | 1,330.97% |
| Jun 30, 2014 | 29.72% |
| Mar 31, 2014 | 19.30% |
| Dec 31, 2013 | 17.26% |
| Sep 30, 2013 | 80.17% |
| Jun 30, 2013 | -20.81% |
| Mar 31, 2013 | -18.91% |
| Dec 31, 2012 | -25.86% |
| Sep 30, 2012 | -54.19% |
| Jun 30, 2012 | 21.24% |
| Mar 31, 2012 | -12.00% |
| Dec 31, 2011 | -67.82% |
| Sep 30, 2011 | -242.78% |
| Jun 30, 2011 | -1,935.24% |
| Mar 31, 2011 | -908.55% |